Serum prolactin concentration in patients taking neuroleptic drugs

Clinical Endocrinology

Volumn 49, Issue 4, 1998, Pages 513-516

  Pollock, Anne ^a   McLaren, E H ^a  

^a NHS GREATER GLASGOW AND CLYDE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

BROMOCRIPTINE; CHLORPROMAZINE; FLUOXETINE; FLUPENTIXOL DECANOATE; FLUVOXAMINE; HALOPERIDOL; NEUROLEPTIC AGENT; PROCYCLIDINE; PROLACTIN; SERTRALINE; SULPIRIDE; THIORIDAZINE; VENLAFAXINE;

ADULT; AMENORRHEA; ARTICLE; CLINICAL ARTICLE; FEMALE; FLUOROMETRY; GALACTORRHEA; HUMAN; HYPERPROLACTINEMIA; MALE; OLIGOMENORRHEA; PRIORITY JOURNAL; PROLACTIN BLOOD LEVEL;

ADOLESCENT; ADULT; ANTIPSYCHOTIC AGENTS; BROMOCRIPTINE; DIAGNOSIS, DIFFERENTIAL; FEMALE; FLUOROIMMUNOASSAY; HUMANS; MIDDLE AGED; PITUITARY NEOPLASMS; PROLACTIN; PROLACTINOMA;

EID: 0031691535     PISSN: 03000664     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2265.1998.00569.x     Document Type: Article

References (11)

1. Checkley, S. (1991) Neuroendocrine effects of psychotropic drugs. Baillière's Clinical Endocrinology and Metabolism, 5, 15-33.
2. Cohn, J.B., Brust, J., DiSerio, F. & Singer, J. (1985) Effect of bromocriptine mesylate on induced hyperprolactinaemia in stabilized psychiatric outpatients undergoing neuroleptic treatment. Pharmacopsychiatry, 13, 173-179.
3. Cowden, E.A., Ratcliffe, W.A., Beastall, G.H. & Ratcliffe, J.G. (1979) Laboratory assessment of prolactin status. Annals of Clinical Biochemistry, 16, 113-121.
4. De Rivera, J.L., Lal, S., Ettigi, P., Hontela, S., Muller, H.F. & Friesen, H.G. (1976) Effect of acute anachronic neuroleptic therapy on serum prolactin levels in men and women of different age groups. Clinical Endocrinology, 5, 273-282.
5. Dencker, S., J. Gios, I., Martensson, E., Norden, T., Nyberg, G., Persson, R., Roman, G., Stockman, O., Svard, K.-& O. (1994) A long-term cross-over pharmacokinetic study comparing perphenazine decanoate and haloperidol decanoate in schizophrenic patients. Psychopharmacology, 114, 24-30.
6. Green, A., I., Brown, W. & A. (1988) Prolactin and neuroleptic drugs. Endocrinology and Metabolism Clinics of North America, 17, 213-223.
7. Jeffcoate, S.L., Bacon, R.R.A., Beastall, G.H., Diver, M.J., Franks, S. & Seth, J. (1986) Assays for prolactin: guidelines for the provision of a clinical biochemistry service. Annals of Clinical Biochemistry, 23, 638-651.
8. Marken, P.A., Radwen, R., F., Fisher, J. & N. (1992) Management of psychotropic-induced hyperprolactinaemia. Clinical Pharmacy, 11, 851-856.
9. Matsuoka, I., Nakai, T., Miyake, M., Hirai, M. & Ikawa, G. (1986) Effects of bromocriptine on neuroleptic-induced amenorrhoea, galactorrhoea and impotence. Japanese Journal of Psychiatry and Neurology, 40, 639-646.
10. Smith, S. (1992) Neuroleptic-associated hyperprolactinaemia. Can it be treated with bromocriptine. Journal of Reproductive Medicine, 37, 737-740.
11. Windgassen, K., Wesselmann, U. & Shulze Monking, H. (1996) Galactorrhoea and hyperprolactinaemia in schizophrenic patients on neuroleptics: frequency and etiology. Neuropsychobiology, 33, 142-146.